KEY ROLE OF EGFR, ERBB2 AND PRPROTEINS IN GENE AND PROTEIN INTERACTIONS WITH VIMENTIN, FOXC1-2, FAK, AND THE BRCA1 IN PREVENTION OF TRIPLE NEGATIVE BREAST CANCER
- Assistant Professor, DBCS, SLOAS, Mohan Babu University, A.P., India-517102.
- Associate Professor, Department of Chemistry, Sanskrithi School of Engineering, Puttaparthi, A.P., India-515134.
- Assistant Professor, Department of Chemistry, BNM Institute of Technology, Bengaluru- 560070.
- Abstract
- Keywords
- Cite This Article as
- Corresponding Author
Studies on protein protein interactions and RNA protein interactions between transcription factors and receptors that act as tumor suppressor proteins play key roles in designing new anticancer drugs for treatment. The BRCA1 RING domain exhibits protein protein interactions with Vimentin, FOXC2, Focal adhesion kinase and EGFR, whereas the EGFR nucleic acid contig shows gene protein interactions with Vimentin, FOXC2, Focal adhesion kinase and BRCA1. ErbB2 and the progesterone receptor play key roles in protein-protein interactions with the BRCA1 RING domain and ErB2 in TNBC, and the PR nucleic acid contig shows gene protein interactions with vimentin, FOXC2, focal adhesion kinase and the BRCA1 RING domain, clearly indicating that the transaction of proteins occurs mostly although noncovalent interactions.
[Eswari Beeram, B. Samba Sivaiah, Swetha Madamala and Shabana palyam (2025); KEY ROLE OF EGFR, ERBB2 AND PRPROTEINS IN GENE AND PROTEIN INTERACTIONS WITH VIMENTIN, FOXC1-2, FAK, AND THE BRCA1 IN PREVENTION OF TRIPLE NEGATIVE BREAST CANCER Int. J. of Adv. Res. (Dec). 1671-1682] (ISSN 2320-5407). www.journalijar.com
Mohan Babu University
India
